BridgeMD
New treatment option for Cerebral Stroke
Official title Telerehabilitation Early After Stroke
ClinicalTrials.gov ID: NCT05625438
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess the safety and feasibility of providing extra doses of rehabilitation therapy for persons with a recent stroke. The therapy treatment targets to improve arm function by introducing telerehabilitation to the bedside of participants during the inpatient rehab admission period.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Stroke that is radiologically verified, due to ischemia or to intracerebral hemorrhage, and with time of stroke onset \<30 days prior to enrollment...
- Unilateral arm motor deficits that are neither trivial (no arm weakness) or devastating (arm plegia). This requires that the baseline Box \& Block...
- Possess enough arm movement to participate in therapy
- Informed consent signed by the subject
You likely can't join if
- A major, active, coexistent neurological or psychiatric disease that would limit study participation, e.g., advanced dementia
- Expectation that patient's cognitive status will likely interfere substantially with playing assigned games or exercises
- Deficits in communication that interfere with reasonable study participation
- Lacking visual acuity, with or without corrective lens, of 20/50 or better in at least one eye
- Subject does not speak sufficient English to comply with study procedures
- Shoulder pain that in the judgement of the study team is likely to substantially limit the amount of telerehabilitation therapy completed
See the full eligibility criteria
- Age 18 years or older
- Stroke that is radiologically verified, due to ischemia or to intracerebral hemorrhage, and with time of stroke onset \<30 days prior to enrollment; or traumatic brain injury.
- Unilateral arm motor deficits that are neither trivial (no arm weakness) or devastating (arm plegia). This requires that the baseline Box \& Block Test score with affected arm to be at least 1 block in 60 seconds but no...
- Possess enough arm movement to participate in therapy
- Informed consent signed by the subject
- Able to follow simple instructions
- Study participation is not likely to be significantly limited by agitated behavior
- A major, active, coexistent neurological or psychiatric disease that would limit study participation, e.g., advanced dementia
- Expectation that patient's cognitive status will likely interfere substantially with playing assigned games or exercises
- Deficits in communication that interfere with reasonable study participation
- Lacking visual acuity, with or without corrective lens, of 20/50 or better in at least one eye
- Subject does not speak sufficient English to comply with study procedures
- Shoulder pain that in the judgement of the study team is likely to substantially limit the amount of telerehabilitation therapy completed
The study team makes the final eligibility decision.
Where it's taking place
- Fullerton, California, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fullerton, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.